MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma

MYC is a notorious oncogene in a vast network of malignancies, whereas liver-specific microRNA- (miR-) 122-5p is downregulated in hepatocellular cancer (HCC). Here, we studied the possible correlation between these two and their involvement in glycolysis in HCC. MYC was overexpressed in HCC tissues...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaofei Wang, Penghua Zhang, Ke Deng
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/1435173
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403076467752960
author Xiaofei Wang
Penghua Zhang
Ke Deng
author_facet Xiaofei Wang
Penghua Zhang
Ke Deng
author_sort Xiaofei Wang
collection DOAJ
description MYC is a notorious oncogene in a vast network of malignancies, whereas liver-specific microRNA- (miR-) 122-5p is downregulated in hepatocellular cancer (HCC). Here, we studied the possible correlation between these two and their involvement in glycolysis in HCC. MYC was overexpressed in HCC tissues and cells compared to normal liver tissues and normal hepatocytes NHC, which predicted a poor survival of HCC sufferers. Functional assays demonstrated that silencing of MYC inhibited the glycolysis in HCC cells, as evidenced by significantly weaker glucose consumption, lactate production, adenosine triphosphate (ATP) levels, and downregulated HK1 and HK2 protein expression. Moreover, MYC bound to the miR-122-5p promoter and repressed the miR-122-5p expression. Rescue experiments showed that miR-122-5p inhibitor rescued the diminished glycolysis after MYC silencing. In addition, lactate dehydrogenase (LDHA) was identified as a downstream target of miR-122-5p. The overexpression of LDHA mitigated the effects of si-MYC and miR-122-5p mimic on glycolysis of HCC cells, respectively. In conclusion, the MYC/miR-122-5p/LDHA axis modulates glycolysis in HCC cells and possibly affects HCC progression.
format Article
id doaj-art-98434d7fc9304cfaaa1370f1c67c2a0e
institution Kabale University
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-98434d7fc9304cfaaa1370f1c67c2a0e2025-08-20T03:37:22ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/1435173MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular CarcinomaXiaofei Wang0Penghua Zhang1Ke Deng2Department of ICUDepartment of Healthy Management CenterDepartment of General SurgeryMYC is a notorious oncogene in a vast network of malignancies, whereas liver-specific microRNA- (miR-) 122-5p is downregulated in hepatocellular cancer (HCC). Here, we studied the possible correlation between these two and their involvement in glycolysis in HCC. MYC was overexpressed in HCC tissues and cells compared to normal liver tissues and normal hepatocytes NHC, which predicted a poor survival of HCC sufferers. Functional assays demonstrated that silencing of MYC inhibited the glycolysis in HCC cells, as evidenced by significantly weaker glucose consumption, lactate production, adenosine triphosphate (ATP) levels, and downregulated HK1 and HK2 protein expression. Moreover, MYC bound to the miR-122-5p promoter and repressed the miR-122-5p expression. Rescue experiments showed that miR-122-5p inhibitor rescued the diminished glycolysis after MYC silencing. In addition, lactate dehydrogenase (LDHA) was identified as a downstream target of miR-122-5p. The overexpression of LDHA mitigated the effects of si-MYC and miR-122-5p mimic on glycolysis of HCC cells, respectively. In conclusion, the MYC/miR-122-5p/LDHA axis modulates glycolysis in HCC cells and possibly affects HCC progression.http://dx.doi.org/10.1155/2022/1435173
spellingShingle Xiaofei Wang
Penghua Zhang
Ke Deng
MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
Analytical Cellular Pathology
title MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
title_full MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
title_fullStr MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
title_full_unstemmed MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
title_short MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
title_sort myc promotes ldha expression through microrna 122 5p to potentiate glycolysis in hepatocellular carcinoma
url http://dx.doi.org/10.1155/2022/1435173
work_keys_str_mv AT xiaofeiwang mycpromotesldhaexpressionthroughmicrorna1225ptopotentiateglycolysisinhepatocellularcarcinoma
AT penghuazhang mycpromotesldhaexpressionthroughmicrorna1225ptopotentiateglycolysisinhepatocellularcarcinoma
AT kedeng mycpromotesldhaexpressionthroughmicrorna1225ptopotentiateglycolysisinhepatocellularcarcinoma